Products for Research Use Only
RegisterLogin

COM902

CAT: 0804-HY-P991391Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991391Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
COM902 is a human IgG4 monoclonal antibody (mAb) targeting TIGIT. COM902 enhances anti-tumor immune responses. COM902 can be used in Multiple myeloma, Solid tumours and Colorectal cancer research. Recommended isotype control: IgG4-lambda[1].
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=[C][M902]
References & Citations
[1]Hansen K, et al. COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade. Cancer Immunol Immunother. 2021 Dec;70 (12) :3525-3540.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P990496-01Anti-PVRIG Antibody (COM701)
HY-RS03011COMMD2 Human Pre-designed siRNA Set A

Alternative Products

CatalogName
T9901A-1553-01COM902
PTX26293Anti-Human TIGIT (COM902)
DHH72416Research Grade Anti-Human TIGIT (COM902)
A136703Anti-TIGIT (COM902) Biosimilar (Monoclonal, IgG4-lambda)

Popular Products